The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2018
Filed:
Oct. 23, 2014
Applicant:
Viiv Healthcare Uk (No. 5) Limited, Brentford, Middlesex, GB;
Inventors:
Annapurna Pendri, South Glastonbury, CT (US);
Guo Li, Wallingford, CT (US);
John A. Bender, Middletown, CT (US);
Zhong Yang, Southington, CT (US);
Alan Xiangdong Wang, Wallingford, CT (US);
Brett R. Beno, Cromwell, CT (US);
Robert A. Fridell, Guilford, CT (US);
Makonen Belema, North Haven, CT (US);
Nicholas A. Meanwell, East Hampton, CT (US);
Robert G. Gentles, Killingworth, CT (US);
Assignee:
ViiV HEALTHCARE UK (NO. 5) LIMITED, Brentford, Middlesex, GB;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/36 (2006.01); A61K 31/357 (2006.01); A61K 31/64 (2006.01); A61K 31/17 (2006.01); A61K 31/18 (2006.01); C07C 275/28 (2006.01); C07C 275/26 (2006.01); C07C 275/18 (2006.01); C07C 275/24 (2006.01); C07C 275/22 (2006.01); C07C 311/62 (2006.01); C07C 311/59 (2006.01); C07C 311/58 (2006.01); C07C 311/56 (2006.01); C07C 311/55 (2006.01); C07D 317/66 (2006.01); C07D 317/62 (2006.01); C07D 205/04 (2006.01); C07D 209/08 (2006.01); C07D 209/10 (2006.01); C07D 213/56 (2006.01); C07D 215/08 (2006.01); C07D 231/12 (2006.01); C07D 249/08 (2006.01); C07D 261/08 (2006.01); C07D 265/36 (2006.01); C07D 271/06 (2006.01); C07D 277/82 (2006.01); C07D 307/38 (2006.01); C07D 317/46 (2006.01); C07D 333/18 (2006.01); C07D 333/28 (2006.01); C07D 333/54 (2006.01); C07D 401/04 (2006.01); C07D 405/12 (2006.01); C07D 407/12 (2006.01); C07D 409/12 (2006.01); C07D 491/08 (2006.01); C07D 495/04 (2006.01);
U.S. Cl.
CPC ...
C07C 311/58 (2013.01); C07D 205/04 (2013.01); C07D 209/08 (2013.01); C07D 209/10 (2013.01); C07D 213/56 (2013.01); C07D 215/08 (2013.01); C07D 231/12 (2013.01); C07D 249/08 (2013.01); C07D 261/08 (2013.01); C07D 265/36 (2013.01); C07D 271/06 (2013.01); C07D 277/82 (2013.01); C07D 307/38 (2013.01); C07D 317/46 (2013.01); C07D 317/66 (2013.01); C07D 333/18 (2013.01); C07D 333/28 (2013.01); C07D 333/54 (2013.01); C07D 401/04 (2013.01); C07D 405/12 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 491/08 (2013.01); C07D 495/04 (2013.01); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05); C07C 2602/08 (2017.05);
Abstract
Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth: